This site is intended for U.S. audiences only.

Financial assistance & glioma support

ServierONE Patient Support Services

At Servier Pharmaceuticals, we know that navigating details of the financial and personal assistance needed for treating your diagnosis can be overwhelming. That’s why we have it all here in one place—so you can easily find the information, direction, and resources to help you and your loved ones throughout your journey. Ask your doctor’s office if they have a financial coordinator who can assist you.

ServierONE Patient Support Services include:

Support with insurance coverage and reimbursement

Financial assistance to help you pay for the medication

Throughout the process, you may be contacted by your specialty pharmacy or Servier over the phone.

Please keep in mind that this call may come from a number you do not recognize.

For more information:

Visit

ServierONE.com

USPatientServices@servier.com

Call

1-800-813-5905

Monday-Friday, 8 AM to 8 PM ET

Download the ServierONE Patient Brochure

ServierONE makes the process of accessing care and support as smooth and worry-free as possible. Learn more about our resources for patients, caregivers, families, and healthcare providers.

Download

The VORANIGO® $25 Copay Program

The $25 Copay Program lowers the out-of-pocket cost of VORANIGO for eligible patients with commercial insurance to no more than $25 per prescription if your copay exceeds that amount.

Enroll

Terms and conditions apply.

Patient Advocacy, Support, and Assistance

There are many patient organizations and online support groups for people living with glioma. To learn more about glioma, to find clinical trials, or to connect with other patients, the list of groups below and other organizations may be useful resources.

Brain tumor support groups

American Brain Tumor Association

End Brain Cancer Initiative

National Brain Tumor Society

Oligo Nation

Groups for all types of cancer

CancerCare

Triage Cancer

Servier provides charitable funding to many patient organizations providing support and education to patients and families. The above list may not include all patient organizations available to patients and families.

Access helpful videos and resources about VORANIGO

Learn more

What is VORANIGO?

VORANIGO (40 mg tablets) is a prescription medicine used to treat adults and children 12 years of age and older with certain types of brain tumors called astrocytoma or oligodendroglioma with an isocitrate dehydrogenase-1 (IDH1) or isocitrate dehydrogenase-2 (IDH2) mutation, following surgery. Your healthcare provider will perform a test to make sure that VORANIGO is right for you. It is not known if VORANIGO is safe and effective in children under 12 years of age.

What are the possible side effects of VORANIGO?

VORANIGO may cause serious side effects, including:

Liver problems. Changes in liver function blood tests may happen during treatment with VORANIGO and can be serious. Your healthcare provider will do blood tests to check your liver function before and during treatment with VORANIGO. Tell your healthcare provider right away if you develop any of the following signs and symptoms of liver problems:

yellowing of your skin or the white part of your eyes (jaundice)

dark tea-colored urine

loss of appetite

pain on the upper right side of your stomach area

feeling very tired or weak

The most common side effects of VORANIGO include:

increased liver enzyme levels in the blood

lack of energy, tiredness

headache

COVID-19

muscle aches or stiffness

diarrhea

nausea

seizure

Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with VORANIGO if you have certain side effects.

VORANIGO may affect fertility in females and males, which may affect the ability to have children. Talk to your healthcare provider if this is a concern for you.

These are not all of the possible side effects of VORANIGO.

Before taking VORANIGO, tell your healthcare provider about all of your medical conditions, including if you:

have liver problems

have kidney problems or are on dialysis

smoke tobacco

are pregnant or plan to become pregnant. VORANIGO can harm your unborn baby

Females who are able to become pregnant:

Your healthcare provider will do a pregnancy test before you start treatment with VORANIGO

You should use effective nonhormonal birth control during treatment with VORANIGO and for 3 months after the last dose. VORANIGO may affect how hormonal contraceptives (birth control) work and cause them to not work well. Talk to your healthcare provider about birth control methods that may be right for you during treatment with VORANIGO

Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with VORANIGO

Males with female partners who are able to become pregnant:

You should use effective birth control during treatment with VORANIGO and for 3 months after the last dose

Tell your healthcare provider right away if your partner becomes pregnant or thinks she may be pregnant during your treatment with VORANIGO

Tell your healthcare provider if you are breastfeeding or plan to breastfeed. It is not known if VORANIGO passes into breast milk. Do not breastfeed during treatment with VORANIGO and for 2 months after the last dose.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. VORANIGO may affect the way other medicines work, and other medicines may affect how VORANIGO works.

Please see Full Prescribing Information.